MannKind Corp (NASDAQ:MNKD)
CAPS Rating:
A biopharmaceutical company focused on the development and commercialization of therapeutic products for diseases such as diabetes and cancer.
A biopharmaceutical company focused on the development and commercialization of therapeutic products for diseases such as diabetes and cancer.
Recs
Affrezza is likely to be approved.